Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease
- PMID: 18256671
- PMCID: PMC3264491
- DOI: 10.1038/nature06616
Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease
Abstract
Senile plaques accumulate over the course of decades in the brains of patients with Alzheimer's disease. A fundamental tenet of the amyloid hypothesis of Alzheimer's disease is that the deposition of amyloid-beta precedes and induces the neuronal abnormalities that underlie dementia. This idea has been challenged, however, by the suggestion that alterations in axonal trafficking and morphological abnormalities precede and lead to senile plaques. The role of microglia in accelerating or retarding these processes has been uncertain. To investigate the temporal relation between plaque formation and the changes in local neuritic architecture, we used longitudinal in vivo multiphoton microscopy to sequentially image young APPswe/PS1d9xYFP (B6C3-YFP) transgenic mice. Here we show that plaques form extraordinarily quickly, over 24 h. Within 1-2 days of a new plaque's appearance, microglia are activated and recruited to the site. Progressive neuritic changes ensue, leading to increasingly dysmorphic neurites over the next days to weeks. These data establish plaques as a critical mediator of neuritic pathology.
Figures
Comment in
-
Neuropathology: Alzheimer's in real time.Nature. 2008 Feb 7;451(7179):638-9. doi: 10.1038/451638a. Nature. 2008. PMID: 18256653 No abstract available.
Similar articles
-
The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.Neuroscience. 2001;105(1):99-107. doi: 10.1016/s0306-4522(01)00169-5. Neuroscience. 2001. PMID: 11483304
-
Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.J Neurosci. 2020 Feb 26;40(9):1956-1974. doi: 10.1523/JNEUROSCI.1871-19.2019. Epub 2020 Jan 24. J Neurosci. 2020. PMID: 31980586 Free PMC article.
-
Use of YFP to study amyloid-beta associated neurite alterations in live brain slices.Neurobiol Aging. 2003 Dec;24(8):1071-7. doi: 10.1016/j.neurobiolaging.2003.04.008. Neurobiol Aging. 2003. PMID: 14643378
-
Neuritic Plaques - Gateways to Understanding Alzheimer's Disease.Mol Neurobiol. 2024 May;61(5):2808-2821. doi: 10.1007/s12035-023-03736-7. Epub 2023 Nov 8. Mol Neurobiol. 2024. PMID: 37940777 Free PMC article. Review.
-
Extracellular Amyloid Deposits in Alzheimer's and Creutzfeldt-Jakob Disease: Similar Behavior of Different Proteins?Int J Mol Sci. 2020 Dec 22;22(1):7. doi: 10.3390/ijms22010007. Int J Mol Sci. 2020. PMID: 33374972 Free PMC article. Review.
Cited by
-
Extracellular vesicles from human-induced pluripotent stem cell-derived neural stem cells alleviate proinflammatory cascades within disease-associated microglia in Alzheimer's disease.J Extracell Vesicles. 2024 Nov;13(11):e12519. doi: 10.1002/jev2.12519. J Extracell Vesicles. 2024. PMID: 39499013 Free PMC article.
-
Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer's Pathogenesis.Mol Neurobiol. 2024 Oct 24. doi: 10.1007/s12035-024-04543-4. Online ahead of print. Mol Neurobiol. 2024. PMID: 39446217 Review.
-
PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies.Theranostics. 2024 Sep 30;14(16):6319-6336. doi: 10.7150/thno.97149. eCollection 2024. Theranostics. 2024. PMID: 39431020 Free PMC article.
-
Isotope Encoded chemical Imaging Identifies Amyloid Plaque Age Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity.bioRxiv [Preprint]. 2024 Oct 11:2024.10.08.617019. doi: 10.1101/2024.10.08.617019. bioRxiv. 2024. PMID: 39416086 Free PMC article. Preprint.
-
The intricate interplay between microglia and adult neurogenesis in Alzheimer's disease.Front Cell Neurosci. 2024 Sep 18;18:1456253. doi: 10.3389/fncel.2024.1456253. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39360265 Free PMC article. Review.
References
-
- Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356. - PubMed
-
- Stokin GB, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease. Science. 2005;307:1282–1288. - PubMed
-
- Jankowsky JL, et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 2001;17:157–165. - PubMed
-
- Jankowsky JL, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 2004;13:159–170. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
